Efficacy of Suvorexant on Post-operative Sleep Disturbance — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Efficacy of Suvorexant on Post-operative Sleep Disturbance — Stella

Home/Postoperative Insomnia/

View on ClinicalTrials.gov

Recruiting

Back to Postoperative Insomnia trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

NewYork-Presbyterian Allen Hospital/CUMC Milstein Hospital Building, New York, New York

Key details

Phase

Post-approval study

Sponsor

Columbia University

Collaborators

Merck Sharp & Dohme LLC

Enrollment target

~92 participants

Started

May 2023

Primary completion

May 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

50 Years – 90 Years

Last updated May 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.